Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Wei Huang

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Expert Opinion on Drug Safety|February 27, 2020
A drug safety evaluation of risankizumab for psoriasisYi-Wei Huang, Tsen-Fang Tsai
Paediatric Drugs|February 6, 2020
Pharmacological Management of Pediatric Pustular PsoriasisYi-Wei Huang, Tsen-Fang Tsai
The Kaohsiung Journal of Medical Sciences|June 29, 2022
Ethambutol-induced subacute cutaneous lupus erythematosusYi-Wei Huang, Wei-Hsin Wu
American Journal of Clinical Dermatology|January 18, 2021
HLA-Cw1 and PsoriasisYi-Wei Huang, Tsen-Fang Tsai
Dermatology and Therapy|July 5, 2019
Remission Duration and Long-Term Outcomes in Patients with Moderate-to-Severe Psoriasis Treated by Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center ExperienceYi-Wei Huang, Tsen-Fang Tsai
European Journal of Dermatology : EJD|June 22, 2024
Topical rapamycin (sirolimus) for the treatment of facial discoid dermatosisYi-Wei Huang, Tsen-Fang Tsai
Frontiers in Medicine|January 10, 2022
Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single CenterYi-Wei Huang, Tsen-Fang Tsai
Huan Jing Ke Xue= Huanjing Kexue|December 20, 2019
[Hazardous Volatile Organic Compound Emission Inventory Study and Its Application in a Typical Chemical Industry in the Yangtze River Delta]Jun Lu, Yi-Wei Huang, Cheng Huang
Expert Review of Clinical Pharmacology|July 18, 2022
Comparison of the relative efficacy of different biologics in different body areas in patients with moderate to severe psoriasis receiving biologics and tofacitinib in phase 3 randomized controlled trials: a 15-year single-center experienceChen-Pu Yeh, Yi-Wei Huang, Tsen-Fang Tsai
BMC Nursing|July 5, 2025
Cross-cultural adaptation of the family coping questionnaire and psychometric evaluation among caregivers of schizophrenic patients in ChinaTing-Ting Ruan, Yi-Wei Huang, Li-Juan Zhang
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Expert Opinion on Drug Safety|February 27, 2020
A drug safety evaluation of risankizumab for psoriasisYi-Wei Huang, Tsen-Fang Tsai
Paediatric Drugs|February 6, 2020
Pharmacological Management of Pediatric Pustular PsoriasisYi-Wei Huang, Tsen-Fang Tsai
The Kaohsiung Journal of Medical Sciences|June 29, 2022
Ethambutol-induced subacute cutaneous lupus erythematosusYi-Wei Huang, Wei-Hsin Wu
American Journal of Clinical Dermatology|January 18, 2021
HLA-Cw1 and PsoriasisYi-Wei Huang, Tsen-Fang Tsai
Dermatology and Therapy|July 5, 2019
Remission Duration and Long-Term Outcomes in Patients with Moderate-to-Severe Psoriasis Treated by Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center ExperienceYi-Wei Huang, Tsen-Fang Tsai
European Journal of Dermatology : EJD|June 22, 2024
Topical rapamycin (sirolimus) for the treatment of facial discoid dermatosisYi-Wei Huang, Tsen-Fang Tsai
Frontiers in Medicine|January 10, 2022
Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single CenterYi-Wei Huang, Tsen-Fang Tsai
Huan Jing Ke Xue= Huanjing Kexue|December 20, 2019
[Hazardous Volatile Organic Compound Emission Inventory Study and Its Application in a Typical Chemical Industry in the Yangtze River Delta]Jun Lu, Yi-Wei Huang, Cheng Huang
Expert Review of Clinical Pharmacology|July 18, 2022
Comparison of the relative efficacy of different biologics in different body areas in patients with moderate to severe psoriasis receiving biologics and tofacitinib in phase 3 randomized controlled trials: a 15-year single-center experienceChen-Pu Yeh, Yi-Wei Huang, Tsen-Fang Tsai
BMC Nursing|July 5, 2025
Cross-cultural adaptation of the family coping questionnaire and psychometric evaluation among caregivers of schizophrenic patients in ChinaTing-Ting Ruan, Yi-Wei Huang, Li-Juan Zhang
Pageof 9